Financial statements Propharma
Balance sheet data of PROPHARMA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 5 487 230,39 | 4 393 590,07 | 4 078 061,63 |
| A. Fixed assets | 467 861,48 | 515 478,33 | 554 882,66 |
| B. Current assets | 5 019 368,91 | 3 878 111,74 | 3 523 178,97 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 |
| Total liabilities | 5 487 230,39 | 4 393 590,07 | 4 078 061,63 |
| A. Equity | 3 147 629,49 | 3 157 278,01 | 2 994 898,62 |
| B. Liabilities and provisions for liabilities | 2 339 600,90 | 1 236 312,06 | 1 083 163,01 |
| I. Long-term liabilities | - | 0,00 | 0,00 |
| II. Short-term liabilities | 1 964 602,09 | 1 206 150,61 | 1 039 095,81 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.